- Raised $707k funding round, Nov 2011
- Raised funding round, May 2015
About
ClearCut Medical develops and commercializes solutions designed for the accurate and effective removal of cancer. Its technology is based on magnetic resonance imaging (MRI) protocols that enable accurate and rapid surface imaging for real-time margin assessment of excised tissue in the operating room. The companys ClearSight MRI System is focused on breast cancer lumpectomies, enabling an intraoperative margin assessment of surgically removed lumps. The system is expected to significantly improve surgical outcomes and reduce re-excision rates. Future applications include prostate and breast cancer biopsies and skin cancer excisions, as well as additional oncological applications, including colorectal and lung cancers. The device is CE marked and has shown industry-leading accuracy in comparison to histopathology in two multi-center trials. ClearCut Medical is initially focusing on breast-conserving surgery, with a TAM of $1.2 billion in the U.S. and Europe. In March 2018, the Australian Department of Healths Therapeutic Goods Administration (TGA) issued a Therapeutic Goods Certificate for the ClearSight MRI System. ClearCut Medicals distribution partner, Surgeon Choice Australia Pty Ltd, will supply the product to key surgical cancer centers in Australia.
Funding history · 2 rounds · $707K total
Q&A
- What is ClearCut Medical's primary focus?
- ClearCut Medical develops and commercializes solutions for the accurate and effective removal of cancer, specifically a portable MRI system for real-time margin assessment during surgery.
- What is the main product offered by ClearCut Medical?
- ClearCut Medical offers the ClearSight MRI System, which focuses on breast cancer lumpectomies to enable intraoperative margin assessment of surgically removed lumps.
- What is the current employee count for ClearCut Medical?
- ClearCut Medical has 11-50 employees.
- What was ClearCut Medical's total funding raised?
- ClearCut Medical has raised a total of $707,070.
- When was ClearCut Medical founded?
- ClearCut Medical was founded in April 2010.
- What is the status of the ClearSight MRI System's regulatory approval in Australia?
- In March 2018, the Australian Department of Health's Therapeutic Goods Administration (TGA) issued a Therapeutic Goods Certificate for the ClearSight MRI System.
- Which company is ClearCut Medical's distribution partner in Australia?
- Surgeon Choice Australia Pty Ltd is ClearCut Medical's distribution partner, responsible for supplying the ClearSight MRI System to surgical cancer centers in Australia.
- What is the primary sector of ClearCut Medical?
- ClearCut Medical operates in the Health Tech & Life Sciences sector.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | clrcut.com |
|---|---|
| linkedin.com/company/73047096 |
Identifiers & details
| Founded | 2010-4 |
|---|---|
| Employees (exact) | 12 |
| Offices | Maple Plain |
Radar intelligence
Web history (Wayback)
| Domain | clrcut.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|